Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for Updates!
Conference Info
 

16th Symposium on Infections in the Immunocompromised Host - Budapest

 

2nd Announcement and Call for Abstracts

 

Past Conferences

Other News
ICHS Past President Wins ASM Award

Steven Holland has been awarded the 2009 Abbott Laboratories Award in Clinical and DIagnostic Immunology.

 

Press Release

 

International Journal of Antimicrobial Agents publishes it's report from the 15th International Symposium on Infections in the Immunocompromised Host.  Click here for more information.

 

Some Presentations are available in PDF format in the Past Meetings Section  Click Here

 

Report from 15th Symposium on "Management of Invasive Fungi"

 

ECIL Press Release Announcing Publication of EJC Supplement

Press Release

 

 

The ICHS is now able to accept your dues payments online.

Pay Dues

 

ECIL 3 latest Guidelines for the Management of Bacterial, Fungal, and Viral Infections Slides

 

Letter from the Executive Director

 

Mycology Initiative Slides for Modules 1 and 2 are now available

 

 

 

 

 

 

 

 

 

 

 

The International Immunocompromised Host Society (ICHS) has been in existence for almost 30 years, and has an active membership of approximately 600 members; mainly practicing clinicians and researchers. ICHS has been holding international conferences on Infections in the Immunocompromised Host every other year, the last meeting was in 2006 was its 15th international conference. The next symposium will take place in June 2010, in Budapest.

 

Recent initiatives within the society have included:

  • ICHS consultancy panels (advisory boards)
  • ICHS Learning Initiatives.  The first of these, the Mycology Initiative, was launched in 2001; module 3 was recently completed and is now available to members.  Modules 1 and 2 are available to anyone interested

 

The ICHS would like to thank its sponsors and exhibitors for their support over the past years.  Past sponsors include:

 

Abbott Laboratories

AstraZeneca

Aventis

Bayer

Biotrin

Bristol-Meyers Squibb

Chiron

Cubist

Fujisawa

Gilead Sciences

GlaxoSmithKline

Hoffman-La Roche

Leo Pharma

Lilly Pharmaceuticals

Merck Inc.

Octapharma

Ortho-McNeil

Pfizer Pharmaceuticals

Pharmacia

Schering Plough Inc

Wyeth Laboratories

Cephalon Cellestis Viropharma
Novartis    

 

As you know sponsors are able to choose which items they support at the biennial symposium, e.g.: conference bags, suites, lunches, satellites etc on a first-come-first-served basis.  ICHS plans for a new way of working to give our valued sponsors the opportunity to become Corporate Members of ICHS. Corporate Members will have priority choice for such items at future ICHS symposia; in addition we plan to meet with our Corporate Members in advance of well attended conferences such as ICAAC and ECCMID to discuss our activities and future plans.

 

Corporate Members will join with the ICHS general membership to promote all aspects of our work with the immunocompromised host.  Corporate Members will have fees to pay, just like general members.  Corporate Members will not have voting rights and cannot hold office, but they will enjoy a range of benefits depending on their level of commitment.

 

ICHS proposes two levels of Corporate Membership, to be paid on the years between the biennial symposium, i.e. 2009, 2011, 2013 etc.:

 

Senior Corporate Member:            $50,000

  • Priority right for exhibition space at biennial meetings
  • Priority right for satellite sessions at biennial meetings
  • ICHS will provide 6 free registrations to the ICHS biennial meeting
  • Access to members-only areas of web site
  • Access to the members mailing list
  • Access to meeting participants mailing list
  • Early information on ICHS symposia and other activities
  • Formal access to council members by email (and phone)
  • Access to ICHS expertise for development of educational programs (with or without CME)
  • Formal right to submit proposal of any kind to the council or general assembly
  • Access to ICHS expertise through Consultancy panels
  • Input on potential faculty members to address hot topics
  • Use of ICHS logo “ICHS Senior Corporate Member” on company materials related to the immunocompromised area
  • Recognition on the ICHS website with hyperlink to company site
  • Regular meetings with ICHS council members, at ICAAC and ECCMID (4 representatives)

 

 

Corporate Member:            $25,000

  • Second choice for exhibition space at biennial meetings
  • Second choice for satellite sessions at biennial meetings
  • ICHS will provide 3 free registrations to the ICHS biennial meeting
  • Access to the members mailing list
  • Access to meeting participants mailing list
  • Early information on all ICHS symposia and other activities
  • Access to ICHS expertise through Consultancy panels
  • Input on potential faculty members to address hot topics
  • Access to member only area of web site
  • Use of ICHS logo “ICHS Corporate Member” on company materials related to the immunocompromised area
  • Recognition on the ICHS website with hyperlink to company site
  • Regular meetings with ICHS council members, ICAAC, ECCMID (2 representatives)

 

With your support we can better serve our membership and friends who attend our meetings; we will be able to implement more ICHS Consultant Panels and learning initiatives in other areas (such as sepsis, HIV, the neonate, etc) and we will be able to attend to the membership responsibilities and keep the society moving forward for the good of our members and patients.

 

 

 

Click here to send a form to the Executive Director

 

Copyright © 2004-2008 Immunocompromised Host Society